Citation Impact
Citing Papers
Complement and microglia mediate early synapse loss in Alzheimer mouse models
2016 StandoutScience
Fibrillar amyloid-β burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease
2009
Exercise training increases size of hippocampus and improves memory
2011 Standout
Sleep Drives Metabolite Clearance from the Adult Brain
2013 StandoutScience
Cerebrospinal fluid tau and ptau 181 increase with cortical amyloid deposition in cognitively normal individuals: Implications for future clinical trials of Alzheimer's disease
2009
Introduction to the recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
2011
Apolipoprotein E and Alzheimer's disease: the influence of apolipoprotein E on amyloid-β and other amyloidogenic proteins
2017
The Low Density Lipoprotein Receptor-related Protein 1 Mediates Uptake of Amyloid β Peptides in an in Vitro Model of the Blood-Brain Barrier Cells
2008
Alzheimer's disease: synaptic dysfunction and Aβ
2009
Origins of Alzheimerʼs disease
2012
Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy
2009
Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
2016 StandoutNature
Lead-induced accumulation of β-amyloid in the choroid plexus: Role of low density lipoprotein receptor protein-1 and protein kinase C
2010
Episodic memory loss is related to hippocampal-mediated -amyloid deposition in elderly subjects
2008
PET imaging of amyloid deposition in patients with mild cognitive impairment
2007
Targeting Aβ and tau in Alzheimer's disease, an early interim report
2009
The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics
2011 Standout
CSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment
2009
Selective Disruption of the Cerebral Neocortex in Alzheimer's Disease
2010
Diagnosis-Independent Alzheimer Disease Biomarker Signature in Cognitively Normal Elderly People
2010
Vascular dementia
2015 Standout
Mechanisms Underlying Inflammation in Neurodegeneration
2010 Standout
Genetics and molecular pathogenesis of sporadic and hereditary cerebral amyloid angiopathies
2009
CD22 blockade restores homeostatic microglial phagocytosis in ageing brains
2019 StandoutNatureNobel
Updated International Consensus Guidelines on the Management of Cytomegalovirus in Solid-Organ Transplantation
2013
Amyloid β Protein Dimer-Containing Human CSF Disrupts Synaptic Plasticity: Prevention by Systemic Passive Immunization
2008
Cortical Hubs Revealed by Intrinsic Functional Connectivity: Mapping, Assessment of Stability, and Relation to Alzheimer's Disease
2009 Standout
Cerebrospinal Fluid β-Amyloid 42 and Tau Proteins as Biomarkers of Alzheimer-Type Pathologic Changes in the Brain
2009
Low-density Lipoprotein Receptor Represents an Apolipoprotein E-independent Pathway of Aβ Uptake and Degradation by Astrocytes
2012
Chronic Traumatic Encephalopathy in Athletes: Progressive Tauopathy After Repetitive Head Injury
2009 Standout
CD33 Alzheimer's disease locus: altered monocyte function and amyloid biology
2013
Decreased cerebrospinal fluid Aβ 42 correlates with brain atrophy in cognitively normal elderly
2009
Alzheimer's disease
2011 Standout
Epidemiology of Alzheimer disease
2011
Use of Leflunomide in Renal Transplant Recipients with Ganciclovir-Resistant/Refractory Cytomegalovirus Infection: A Case Series from the University of Chicago
2015
A century-old debate on protein aggregation and neurodegeneration enters the clinic
2006 Nature
Mild Cognitive Impairment
2011 Standout
apoE isoform–specific disruption of amyloid β peptide clearance from mouse brain
2008
Identifying incipient dementia individuals using machine learning and amyloid imaging
2017
Lifespan brain activity, β-amyloid, and Alzheimer's disease
2011
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria
2007 Standout
Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease
2010
Randomized Trial of Valganciclovir Versus Valacyclovir Prophylaxis for Prevention of Cytomegalovirus in Renal Transplantation
2014
Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory
2008 Standout
Alzheimer disease: Epidemiology, diagnostic criteria, risk factors and biomarkers
2014
CSF Biomarkers
2009
TREM2 Lipid Sensing Sustains the Microglial Response in an Alzheimer’s Disease Model
2015 Standout
Structural and functional features of central nervous system lymphatic vessels
2015 StandoutNature
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
2019 Standout
CSF biomarker levels in early and late onset Alzheimer's disease
2008
High-performance medicine: the convergence of human and artificial intelligence
2018 Standout
Lymphatic drainage of the brain and the pathophysiology of neurological disease
2008
Alzheimer's disease
2015
FreeSurfer
2012 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
2009 Standout
Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
2010
APOE predicts amyloid‐beta but not tau Alzheimer pathology in cognitively normal aging
2009
Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives
2010
Cognition, reserve, and amyloid deposition in normal aging
2009
Dynamic Analysis of Amyloid β-Protein in Behaving Mice Reveals Opposing Changes in ISF versus Parenchymal Aβ during Age-Related Plaque Formation
2011
Power failure: why small sample size undermines the reliability of neuroscience
2013 Standout
Flotillin-Dependent Clustering of the Amyloid Precursor Protein Regulates Its Endocytosis and Amyloidogenic Processing in Neurons
2008 StandoutNobel
Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
2013 Standout
Association of Increased Cortical Soluble Aβ42 Levels With Diffuse Plaques After Severe Brain Injury in Humans
2007
Microglia, amyloid, and cognition in Alzheimer's disease: An [11C](R)PK11195-PET and [11C]PIB-PET study
2008
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
Alzheimer's disease
2016 Standout
Cerebrospinal Fluid tau/β-Amyloid42 Ratio as a Prediction of Cognitive Decline in Nondemented Older Adults
2007
Disruption of Functional Connectivity in Clinically Normal Older Adults Harboring Amyloid Burden
2009
Imaging of amyloid burden and distribution in cerebral amyloid angiopathy
2007
Anti-Aβ Drug Screening Platform Using Human iPS Cell-Derived Neurons for the Treatment of Alzheimer's Disease
2011 StandoutNobel
Biomarker Modeling of Alzheimer’s Disease
2013
The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation
2018 Standout
The Role of Apolipoprotein E in Alzheimer's Disease
2009
Mechanism of Cerebral β-Amyloid Angiopathy: Murine and Cellular Models
2006
Alzheimer's Disease
2010 Standout
Long-Term Outcomes of Pre-emptive Valganciclovir Compared with Valacyclovir Prophylaxis for Prevention of Cytomegalovirus in Renal Transplantation
2012
Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease
2009
Distinct cerebrospinal fluid amyloid β peptide signatures in sporadic and PSEN1A431E-associated familial Alzheimer's disease
2010
The Amyloid State of Proteins in Human Diseases
2012 Standout
Relationship of Cerebrospinal Fluid Markers to11C-PiB and18F-FDDNP Binding
2009
Evaluating Amyloid-β Oligomers in Cerebrospinal Fluid as a Biomarker for Alzheimer’s Disease
2013
Systematic Mutagenesis of α-Synuclein Reveals Distinct Sequence Requirements for Physiological and Pathological Activities
2012 StandoutNobel
Heavy-Chain Complementarity-Determining Regions Determine Conformation Selectivity of Anti-Aβ Antibodies
2010
Amyloid biomarkers in Alzheimer's disease
2015
Clinical amyloid imaging in Alzheimer's disease
2011
Infection in Solid-Organ Transplant Recipients
2007 Standout
Pittsburgh Compound B Imaging and Prediction of Progression From Cognitive Normality to Symptomatic Alzheimer Disease
2009
Preclinical Evidence of Alzheimer Changes
2009
The Role of the Cell Surface LRP and Soluble LRP in Blood-Brain Barrier Aβ Clearance in Alzheimers Disease
2008
Sorting through the Cell Biology of Alzheimer's Disease: Intracellular Pathways to Pathogenesis
2006
Evidence for Ordering of Alzheimer Disease Biomarkers
2011
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
The dynamics of Alzheimer's disease biomarkers in the Alzheimer's Disease Neuroimaging Initiative cohort
2010
Epidemiology of Alzheimer's disease and other forms of dementia in China, 1990–2010: a systematic review and analysis
2013 Standout
11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment
2008
A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease
2017 Standout
Single-cell transcriptomic analysis of Alzheimer’s disease
2019 StandoutNature
Multimodal techniques for diagnosis and prognosis of Alzheimer's disease
2009 Nature
The Dynamics of Cortical and Hippocampal Atrophy in Alzheimer Disease
2011
Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders
2011 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Beta Amyloid in Alzheimer's Disease: Increased Deposition in Brain Is Reflected in Reduced Concentration in Cerebrospinal Fluid
2009
Amyloid Precursor Protein Regulates Brain Apolipoprotein E and Cholesterol Metabolism through Lipoprotein Receptor LRP1
2007
Soluble amyloid precursor protein (APP) regulates transthyretin and Klotho gene expression without rescuing the essential function of APP
2010 StandoutNobel
The PREVENT study: a prospective cohort study to identify mid-life biomarkers of late-onset Alzheimer's disease
2012
Imaging amyloid deposition in Lewy body diseases
2008
Longitudinal β-Amyloid Deposition and Hippocampal Volume in Preclinical Alzheimer Disease and Suspected Non–Alzheimer Disease Pathophysiology
2016
Imaging β-amyloid burden in aging and dementia
2007
The Amyloid Beta Peptide: A Chemist’s Perspective. Role in Alzheimer’s and Fibrillization
2012
Lecanemab in Early Alzheimer’s Disease
2022 Standout
Relationships between biomarkers in aging and dementia
2009
Active and Passive Immunotherapy for Neurodegenerative Disorders
2008
MRI and CSF biomarkers in normal, MCI, and AD subjects
2009
Nanozymes: Classification, Catalytic Mechanisms, Activity Regulation, and Applications
2019 Standout
Low-density lipoprotein receptor overexpression enhances the rate of brain-to-blood Aβ clearance in a mouse model of β-amyloidosis
2012
Transport Pathways for Clearance of Human Alzheimer's Amyloid β-Peptide and Apolipoproteins E and J in the Mouse Central Nervous System
2006
Human apoE Isoforms Differentially Regulate Brain Amyloid-β Peptide Clearance
2011
Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease
2014
Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients
2013
New ELISAs with high specificity for soluble oligomers of amyloid β‐protein detect natural Aβ oligomers in human brain but not CSF
2013
Integrated Nanozymes with Nanoscale Proximity for in Vivo Neurochemical Monitoring in Living Brains
2016
Slow wave sleep disruption increases cerebrospinal fluid amyloid-β levels
2017
Meta-Analysis of Plasma Amyloid-β levels in Alzheimer's Disease
2011
Accuracy of Brain Amyloid Detection in Clinical Practice Using Cerebrospinal Fluid β-Amyloid 42
2014
Molecular imaging with Pittsburgh Compound B confirmed at autopsy: a case report.
2007
Alzheimer’s Disease: The Challenge of the Second Century
2011
The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
2011 Standout
Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes (II)
2018 Standout
Amyloid, hypometabolism, and cognition in Alzheimer disease
2006
Core candidate neurochemical and imaging biomarkers of Alzheimer's disease
2007
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
2011 Standout
Intracellular metalloprotease activity controls intraneuronal Aβ aggregation and limits secretion of Aβ via exosomes
2018
Supramolecular Helical Systems: Helical Assemblies of Small Molecules, Foldamers, and Polymers with Chiral Amplification and Their Functions
2016 Standout
The biology , function , and biomedical applications of exosomes
2020 StandoutScience
MRI and CSF biomarkers in normal, MCI, and AD subjects
2009
Plasma tau in Alzheimer disease
2016 StandoutNobel
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Amyloid precursor protein (APP) traffics from the cell surface via endosomes for amyloid β (Aβ) production in the trans -Golgi network
2012 StandoutNobel
Proteases and Proteolysis in Alzheimer Disease: A Multifactorial View on the Disease Process
2010
CSF biomarkers in frontotemporal lobar degeneration with known pathology
2008
Evaluation of Tau Imaging in Staging Alzheimer Disease and Revealing Interactions Between β-Amyloid and Tauopathy
2016
Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease
2012
Effect of 1 Night of Total Sleep Deprivation on Cerebrospinal Fluid β-Amyloid 42 in Healthy Middle-Aged Men
2014
Valganciclovir Prophylaxis against Cytomegalovirus Impairs Lymphocyte Proliferation and Activation in Renal Transplant Recipients
2011
Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients
2013
Works of Michael Spinner being referenced
Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ 42 in humans
2005
Impact of Prophylactic Versus Preemptive Valganciclovir on Long-Term Renal Allograft Outcomes
2010
The Low Density Lipoprotein Receptor Regulates the Level of CentralNervous System Human and Murine Apolipoprotein E but Does Not Modify AmyloidPlaque Pathology in PDAPPMice
2005
ApoAI Deficiency Results in Marked Reductions in Plasma Cholesterol But No Alterations in Amyloid-β Pathology in a Mouse Model of Alzheimer's Disease-Like Cerebral Amyloidosis
2004
Amyloid-β Dynamics Correlate with Neurological Status in the Injured Human Brain
2008 Science